Glycaemic control and cardiovascular risk factors in type 2 diabetes: A population-based study

Diabetic Medicine

Volumn 15, Issue 4, 1998, Pages 304-307

  Bruno, G ^a,c   Cavallo Perin, P ^b   Bargero, G ^a   Borra, M ^b   D'Errico, N ^a   Pagano, G ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b Santo Splrito Hospital   (Italy)

^c Dipartimento di Medicina Interna   (Italy)

Author keywords

Antidiabetic treatment; Cardiovascular risk factors; Glycaemic control; Survey

Indexed keywords

CHOLESTEROL; FIBRINOGEN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ARTICLE; COMORBIDITY; DIET THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; RISK FACTOR;

BLOOD GLUCOSE; CHOLESTEROL; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; FIBRINOGEN; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; MALE; OBESITY; RISK FACTORS; TRIGLYCERIDES;

EID: 0031981331     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199804)15:4<304::AID-DIA571>3.0.CO;2-D     Document Type: Article

References (16)

1. Colwell JA. DCCT findings. Applicability and implications for NIDDM. Diabetes Review 1994; 2: 277-289.
2. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994; 43: 960-967.
3. Muggeo M, Verlato G, Bonora E, Ciani F, Moghetti P, Eastman R, Crepaldi G, de Marco R. Long-term instability of fasting plasma glucose predicts mortality in elderly NIDDM patients the Verona Diabetes Study. Diabetologia 1995; 38: 672-679.
4. Ferrannini E, Stern MP, Galvan AQ, Mitchel BD, Haffner SM. Impact of associated conditions on glycemie control of NIDDM patients. Diabetes Care 1992; 15: 508-514.
5. Papoz L, Vauzelle F, Vexian P, Cathelineau G. Pattern of treatment among diabetic patients in France. Diabetes Care 1988; 11: 586-591.
6. Stalhammmar J, Bergman U, Boman K, Dahlen M. Metabolic control in diabetic subjects in three Swedish areas with high, medium, and low sales of antidiabetic drugs. Diabetes Care 1991; 14: 12-19.
7. Pagano G, Bargero G, Vuolo A, Bruno G. Prevalence and clinical features of known type 2 diabetes in the elderly: a population-based study. DiabeticMed 1993; 11:475-479.
8. Bruno G, Bargero G, Vuolo A, Pisu E, Pagano G. A population-based prevalence survey of known diabetes mellitus in Northern Italy based upon multiple independent sources of ascertainment. Diabetologia 1992; 35: 851-856.
9. Alberti KGMM, Cries FA, Jervel J, Krans HJ for the European NIDDM Policy Group. A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM). Diabetic Med 1994; 11: 899-909.
10. Bruno G, LaPorte RE, Merletti F, Biggeri A, MacCarty D, Pagano G. National diabetes programs. Application of capture-recapture to count diabetes? Diabetes Care 1994; 17: 548-556.
11. Bruno G, Cavallo-Perin P, Bargero G, Borra M, Calvi V, D'Errico N, et al. Prevalence and risk factors for microand macroalbuminuria in an Italian population-based cohort of NIDDM subjects. Diabetes Care 1996; 19: 43-47.
12. Consensus statement. Treatment of hypertension in diabetes. Diabetes Care 1993; 16: 1394-1401.
13. Clauss A. Measurement of fibrinogen. Acta Haematol 1957; 17: 237-242.
14. SAS/STAT Guide for Personal Computers. Version 6 Edition. Cary, NC: SAS Institute Inc., 1987.
15. Bruno G, Cavallo-Perin P, Bargero G, Borra M, D'Errico N, Pagano G. Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-dependent diabetes. Ann Intern Med 1996; 125: 653-657.
16. Ceriello A. Hemostatic abnormalities in diabetes mellitus: consequence of hyperglycemia. Nutr Metab Cardiovasc Dis 1995; 5: 237-240.